Stocksigma LogoStocksigma Logo

Crisil ESG Ratings Assigns 'Crisil ESG 65' to Hikal for FY26

Crisil ESG Ratings & Analytics assigned an unsolicited ESG rating of 'Crisil ESG 65' to Hikal Limited for FY26 under the Pharmaceuticals sector, per its

Crisil ESG Ratings Assigns 'Crisil ESG 65' to Hikal for FY26

Hikal Ltd 路 Others (Uncategorized) 路 29 Sept 2026, 9:45 pm

Crisil ESG Ratings Assigns 'Crisil ESG 65' to Hikal for FY26 Crisil ESG Ratings & Analytics assigned an unsolicited ESG rating of 'Crisil ESG 65' to Hikal Limited for FY26 under the Pharmaceuticals sector, per its report dated 28th Sep'26. Hikal outperformed peers across renewable energy mix, waste recycling, low water withdrawal in stressed zones, employee safety, zero recalls, and low complaint intensity. Governance metrics reflected strong board diversity, high independent director attendance, and zero whistleblower or investor complaints. The independent rating was derived entirely from public domain data without direct company engagement.

Original exchange filing (PDF)

More announcements from Hikal Ltd

All Hikal Ltd announcements